Chronic proton pump inhibitor use is not associated with an increased risk of osteoporotic fracture

被引:0
作者
Targownik, L. E. [1 ]
Leslie, W. D. [1 ]
Lix, L. M. [1 ]
Metge, C. J. [1 ]
Prior, H. J. [1 ]
Leong, S. [1 ]
机构
[1] Univ Manitoba, Winnipeg, MB, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
S351
引用
收藏
页码:S118 / S118
页数:1
相关论文
共 50 条
  • [31] PROTON PUMP INHIBITOR USE AND THE RISK OF STROKE
    Nguyen, Long H.
    Lochhead, Paul
    Joshi, Amit D.
    Cao, Yin
    Ma, Wenjie
    Khalili, Hamed
    Rimm, Eric B.
    Rexrode, Kathryn M.
    Chan, Andrew T.
    GASTROENTEROLOGY, 2018, 154 (06) : S100 - S101
  • [32] Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
    Arora, Pradeep
    Gupta, Anu
    Golzy, Mojgan
    Patel, Nilang
    Carter, Randolph L.
    Jalal, Kabir
    Lohr, James W.
    BMC Nephrology, 2016, 17
  • [33] Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
    Pradeep Arora
    Anu Gupta
    Mojgan Golzy
    Nilang Patel
    Randolph L. Carter
    Kabir Jalal
    James W. Lohr
    BMC Nephrology, 17
  • [34] Hypomagnesemia Is Not Associated With Chronic Proton Pump Inhibitor (PPI) Use in Pediatric Patients
    Di Palma, Joan S.
    Kenyon, Suzanne C.
    Abraham, Sheeja K.
    del Rosario, Fernando
    GASTROENTEROLOGY, 2013, 144 (05) : S858 - S859
  • [35] Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes
    Chou, Ya-Shuan
    Jiang, He-Jiun
    Chen, Chung-Hwan
    Ho, Pei-Shan
    Lee, Tien-Ching
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] Letter: association between proton pump inhibitor use and fracture risk - causality or confounding?
    Sugiyama, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (11) : 1569 - 1570
  • [37] Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes
    Ya-Shuan Chou
    He-Jiun Jiang
    Chung-Hwan Chen
    Pei-Shan Ho
    Tien-Ching Lee
    Scientific Reports, 10
  • [38] Proton Pump Inhibitor Use and Fracture Risk: An Update of Drug Safety Communication Needed?
    Sugiyama, Toshihiro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (02) : 360 - 361
  • [39] Proton Pump Inhibitor Use Is Associated With a Reduced Risk of Infection with Intestinal Protozoa
    Sheele, Johnathan M.
    WILDERNESS & ENVIRONMENTAL MEDICINE, 2017, 28 (04) : 339 - 341
  • [40] Proton pump inhibitor use is associated with a high risk of spontaneous bacterial peritonitis
    Bajaj, Jasmohan S.
    Hafeezullah, Muhammad
    Zadvornova, Yelena
    Saeian, Kia
    HEPATOLOGY, 2007, 46 (04) : 565A - 565A